Wedbush Initiates Coverage On Pharvaris with Outperform Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico has initiated coverage on Pharvaris (NASDAQ:PHVS) with an Outperform rating and a price target of $27.
September 25, 2023 | 12:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pharvaris has received an Outperform rating from Wedbush with a price target of $27.
The Outperform rating from Wedbush indicates a positive outlook for Pharvaris. The price target of $27 suggests a potential upside from the current price. This could lead to increased investor interest and a potential increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100